10 June 2026
A wide range of critical issues were discussed, including the rising lung cancer burden in Malaysia, optimal modality and frequency of screening, biomarker testing, compliance with local CPG guidelines, access to cutting-edge therapies, and various strategies to surmount real-world challenges.